Jackson Hole Capital Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,481
Closed -$2.47M 286
2025
Q1
$2.47M Sell
36,481
-492
-1% -$29.4K 0.49% 61
2024
Q4
$1.66M Sell
36,973
-6,392
-15% -$359K 0.34% 81
2024
Q3
$2.73M Sell
43,365
-1,315
-3% -$76.7K 0.57% 51
2024
Q2
$2.64M Buy
44,680
+2,359
+6% +$148K 0.57% 51
2024
Q1
$3.38M Buy
42,321
+1,761
+4% +$135K 0.76% 36
2023
Q4
$3.2M Buy
40,560
+3,670
+10% +$261K 0.81% 32
2023
Q3
$2.58M Sell
36,890
-136
-0.4% -$9.64K 0.75% 32
2023
Q2
$2.56M Buy
37,026
+565
+2% +$40.2K 0.7% 37
2023
Q1
$2.74M Buy
36,461
+576
+2% +$48.3K 0.72% 36
2022
Q4
$3.34M Buy
35,885
+360
+1% +$34.7K 1% 30
2022
Q3
$3.39M Sell
35,525
-760
-2% -$75.2K 1.04% 25
2022
Q2
$3.36M Buy
36,285
+465
+1% +$45.4K 1.05% 26
2022
Q1
$3.63M Buy
35,820
+2,297
+7% +$241K 1.04% 29
2021
Q4
$3.46M Sell
33,523
-900
-3% -$83.2K 1.08% 26
2021
Q3
$2.92M Buy
34,423
+3,020
+10% +$253K 0.95% 32
2021
Q2
$2.62M Buy
31,403
+971
+3% +$79.5K 0.91% 34
2021
Q1
$2.29M Buy
30,432
+3,976
+15% +$290K 0.94% 31
2020
Q4
$1.81M Buy
+26,456
New +$1.72M 0.82% 43

Other funds holding CVS

Jackson Hole Capital Partners's CVS Position: Q2 2025 in Review

Jackson Hole Capital Partners sold out of CVS Health (CVS) in Q2 2025, closing a stake of 36,481 shares — an estimated $2.47M sold.

Jackson Hole Capital Partners first reported a position in CVS in Q4 2020 and held it in 18 quarters. The position peaked at $3.63M in Q1 2022. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Jackson Hole Capital Partners reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Jackson Hole Capital Partners sold 36,481 CVS Health shares in Q2 2025, an estimated $2.47M.
  • Jackson Hole Capital Partners first reported a position in CVS Health in Q4 2020 and held it in 18 quarters.
  • Jackson Hole Capital Partners's CVS Health position peaked at $3.63M in Q1 2022.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Jackson Hole Capital Partners's 13F filing for Q2 2025, filed 31 Jul 2025.